Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19-Reference-Cited by-同舟云学术

Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19

Published:2021-04 Issue:4 Volume:27 Page:668-676
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Gaziano Liam, ,Giambartolomei Claudia^ORCID,Pereira Alexandre C.,Gaulton Anna^ORCID,Posner Daniel C.^ORCID,Swanson Sonja A.,Ho Yuk-Lam,Iyengar Sudha K.,Kosik Nicole M.^ORCID,Vujkovic Marijana^ORCID,Gagnon David R.^ORCID,Bento A. Patrícia^ORCID,Barrio-Hernandez Inigo,Rönnblom Lars^ORCID,Hagberg Niklas^ORCID,Lundtoft Christian^ORCID,Langenberg Claudia^ORCID,Pietzner Maik^ORCID,Valentine Dennis,Gustincich Stefano^ORCID,Tartaglia Gian Gaetano^ORCID,Allara Elias^ORCID,Surendran Praveen,Burgess Stephen^ORCID,Zhao Jing Hua,Peters James E.^ORCID,Prins Bram P.^ORCID,Angelantonio Emanuele Di,Devineni Poornima,Shi Yunling,Lynch Kristine E.,DuVall Scott L.,Garcon Helene,Thomann Lauren O.,Zhou Jin J.,Gorman Bryan R.,Huffman Jennifer E.^ORCID,O’Donnell Christopher J.^ORCID,Tsao Philip S.,Beckham Jean C.,Pyarajan Saiju,Muralidhar Sumitra,Huang Grant D.,Ramoni Rachel,Beltrao Pedro^ORCID,Danesh John,Hung Adriana M.,Chang Kyong-Mi^ORCID,Sun Yan V.^ORCID,Joseph Jacob,Leach Andrew R.,Edwards Todd L.,Cho Kelly,Gaziano J. Michael,Butterworth Adam S.^ORCID,Casas Juan P.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-021-01310-z.pdf

Reference59 articles.

1. Horby, P. et al. Dexamethasone in hospitalized patients with COVID-19—preliminary report. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2021436 (2020).

2. Beigel, J. H. et al. Remdesivir for the treatment of COVID-19—final report. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2007764 (2020).

3. Kalil, A. C. et al. Baricitinib plus remdesivir for hospitalized adults with COVID-19. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2031994 (2020).

4. Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856–860 (2015).

5. Cohen, J. C., Boerwinkle, E., Mosley, T. H. Jr. & Hobbs, H. H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354, 1264–1272 (2006).

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-Wide Mendelian Randomization Identifies Ferroptosis-Related Drug Targets for Alzheimer’s Disease;Journal of Alzheimer's Disease Reports;2024-09-05

2. Association between ursodeoxycholic acid use and COVID-19 in individuals with chronic liver disease: a nationwide case-control study in South Korea;Virology Journal;2024-08-27

3. Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights from Genetic and Experimental Models;2024-08-12

4. Causality of genetically determined metabolites and metabolic pathways on joint diseases: a two-sample mendelian randomization study;2024-08-10

5. Unveiling potential drug targets for lung squamous cell carcinoma through the integration of druggable genome and genome-wide association data;Frontiers in Genetics;2024-08-08